 |
42 Diseases |  |
12 Trials |
|
12 Trials |  |
1286 News |  |
| «12...3456789101112131415» |
- lisdexamfetamine / Generic mfg.
Trial primary completion date: Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation (clinicaltrials.gov) - Jun 17, 2015
P2, N=50, Recruiting, Sponsor: University of California, Los Angeles
Trial primary completion date: Jul 2015 --> Jul 2016
- |||||||||| lisdexamfetamine / Generic mfg.
New P3 trial: Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder (clinicaltrials.gov) - Jun 9, 2015
P3, N=100, Not yet recruiting, Sponsor: Shire
- || lisdexamfetamine / Generic mfg.
Trial completion: Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits (clinicaltrials.gov) - Jun 4, 2015
P3, N=22, Completed, Sponsor: Vanderbilt University
Trial primary completion date: Jul 2015 --> Jul 2016 Active, not recruiting --> Completed
- ||||||| lisdexamfetamine / Generic mfg.
Trial completion, Enrollment change: Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder (clinicaltrials.gov) - Apr 28, 2015
P3, N=148, Completed, Sponsor: Shire
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=412 --> 148
- | lisdexamfetamine / Generic mfg.
Enrollment open: Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder (clinicaltrials.gov) - Apr 14, 2015
P2, N=20, Recruiting, Sponsor: Shire
Active, not recruiting --> Completed | N=412 --> 148 Not yet recruiting --> Recruiting
- | lisdexamfetamine / Generic mfg.
New P2 trial: Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder (clinicaltrials.gov) - Apr 2, 2015
P2, N=20, Not yet recruiting, Sponsor: Shire
- || lisdexamfetamine / Generic mfg.
Enrollment change: Imaging the Effects of Stimulant Medication on Emotional Lability in Patients With ADHD (clinicaltrials.gov) - Mar 27, 2015
P=N/A, N=100, Recruiting, Sponsor: New York State Psychiatric Institute
Not yet recruiting --> Recruiting N=50 --> 100
- lisdexamfetamine / Generic mfg.
Trial primary completion date: Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity (clinicaltrials.gov) - Feb 5, 2015
P4, N=40, Recruiting, Sponsor: Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada
N=50 --> 100 Trial primary completion date: Dec 2014 --> Jul 2015
- ||||||| lisdexamfetamine / Generic mfg.
Trial completion: Open Label Extension in Adults With Binge Eating Disorder (BED) (clinicaltrials.gov) - Jan 9, 2015
P3, N=604, Completed, Sponsor: Shire
Trial primary completion date: Dec 2014 --> Jul 2015 Active, not recruiting --> Completed
- lisdexamfetamine / Generic mfg.
Trial primary completion date: TMF: Sequencing Treatments for Mothers With ADHD and Their At - Risk Children (clinicaltrials.gov) - Oct 4, 2014
P4, N=20, Recruiting, Sponsor: Seattle Children's Hospital
Active, not recruiting --> Completed Trial primary completion date: Jun 2014 --> Jun 2016
- |||| lisdexamfetamine / Generic mfg.
Trial completion: Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) (clinicaltrials.gov) - Oct 4, 2014
P4, N=314, Completed, Sponsor: Shire
Trial primary completion date: Jun 2014 --> Jun 2016 Active, not recruiting --> Completed
- lisdexamfetamine / Generic mfg.
Trial primary completion date: Imaging the Effects of Stimulant Medication on Emotional Lability in Patients With ADHD (clinicaltrials.gov) - Sep 28, 2014
P=N/A, N=50, Recruiting, Sponsor: New York State Psychiatric Institute
Active, not recruiting --> Completed Trial primary completion date: Mar 2014 --> Mar 2016
- |||| lisdexamfetamine / Generic mfg.
Trial primary completion date: Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder (clinicaltrials.gov) - Sep 22, 2014
P3, N=412, Active, not recruiting, Sponsor: Shire
Trial primary completion date: Mar 2014 --> Mar 2016 Trial primary completion date: Oct 2015 --> Apr 2015
- ||| centanafadine SR (EB-1020) / Otsuka
Trial completion, Enrollment change: A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users (clinicaltrials.gov) - Aug 15, 2014
P1, N=80, Completed, Sponsor: Neurovance, Inc.
Trial primary completion date: Oct 2015 --> Apr 2015 Recruiting --> Completed | N=32 --> 80
- methylphenidate tablet / Generic mfg., dextroamphetamine immediate release / Generic mfg.
Clinical: Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder (clinicaltrials.gov) - Aug 7, 2014
P=N/A, N=200, Recruiting, Sponsor: Lily Hechtman
- ||||| lisdexamfetamine / Generic mfg.
Enrollment closed: Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder (clinicaltrials.gov) - Aug 5, 2014
P3, N=412, Active, not recruiting, Sponsor: Shire
Recruiting --> Completed | N=32 --> 80 Recruiting --> Active, not recruiting
- lisdexamfetamine / Generic mfg., Tenex (guanfacine immediate release tablet) / Dr. Reddy's
New P4 trial: Omega-3 Supplementation to ADHD Medication in Children (clinicaltrials.gov) - Jul 30, 2014
P4, N=20, Recruiting, Sponsor: Massachusetts General Hospital
- |||| lisdexamfetamine / Generic mfg.
Trial primary completion date: SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder (clinicaltrials.gov) - Jul 21, 2014
P3, N=383, Completed, Sponsor: Shire
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2013 --> Sep 2013
- lisdexamfetamine / Generic mfg.
Enrollment open: Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence (clinicaltrials.gov) - Jul 1, 2014
P1, N=60, Recruiting, Sponsor: University of Arkansas
Trial primary completion date: Jun 2013 --> Sep 2013 Not yet recruiting --> Recruiting
- | lisdexamfetamine / Generic mfg.
New P4 trial: LEIA: Lisdexamfetamine's Effect In ADHD in the Brain and Cognition (clinicaltrials.gov) - Jun 24, 2014
P4, N=40, Recruiting, Sponsor: University of California, Davis
- lisdexamfetamine / Generic mfg.
Enrollment change: Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance? (clinicaltrials.gov) - Jun 13, 2014
P4, N=38, Completed, Sponsor: Florida International University
Not yet recruiting --> Recruiting N=70 --> 38
- lisdexamfetamine / Generic mfg.
Trial completion: Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance? (clinicaltrials.gov) - Jun 13, 2014
P4, N=38, Completed, Sponsor: Florida International University
N=70 --> 38 Recruiting --> Completed
- |||| lisdexamfetamine / Generic mfg.
Trial completion: Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder (clinicaltrials.gov) - Jun 1, 2014
P4, N=549, Completed, Sponsor: Shire
Recruiting --> Completed Active, not recruiting --> Completed
- | centanafadine SR (EB-1020) / Otsuka
New P1 trial: A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users (clinicaltrials.gov) - May 20, 2014
P1, N=32, Recruiting, Sponsor: Neurovance, Inc.
- centanafadine SR (EB-1020) / Otsuka
Enrollment open: A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users (clinicaltrials.gov) - May 18, 2014
P1, N=32, Recruiting, Sponsor: Neurovance, Inc.
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Clinical: Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) (clinicaltrials.gov) - May 18, 2014
P=N/A, N=326, Recruiting, Sponsor: McGill University Health Center
- methylphenidate tablet / Generic mfg., atomoxetine / Generic mfg.
Clinical: ADAPT: ADHD Medication and Predictors of Treatment Outcome (clinicaltrials.gov) - May 8, 2014
P=N/A, N=2000, Not yet recruiting, Sponsor: Karolinska Institutet
- lisdexamfetamine / Generic mfg.
Trial primary completion date, MRI: LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women (clinicaltrials.gov) - May 1, 2014
P4, N=14, Completed, Sponsor: University of Pennsylvania
Not yet recruiting --> Recruiting Trial primary completion date: Dec 2013 --> Apr 2014
- || lisdexamfetamine / Generic mfg.
Trial primary completion date: Attention & Memory Impairments in Menopausal Women (clinicaltrials.gov) - May 1, 2014
P4, N=57, Completed, Sponsor: University of Pennsylvania
Trial primary completion date: Dec 2013 --> Apr 2014 Trial primary completion date: Dec 2013 --> Apr 2014
- lisdexamfetamine / Generic mfg.
Trial completion date, MRI: LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women (clinicaltrials.gov) - May 1, 2014
P4, N=14, Completed, Sponsor: University of Pennsylvania
Trial primary completion date: Dec 2013 --> Apr 2014 Trial completion date: Dec 2013 --> Apr 2014
- || lisdexamfetamine / Generic mfg.
Trial completion date: Attention & Memory Impairments in Menopausal Women (clinicaltrials.gov) - May 1, 2014
P4, N=57, Completed, Sponsor: University of Pennsylvania
Trial completion date: Dec 2013 --> Apr 2014 Trial completion date: Jan 2014 --> Apr 2014
- | lisdexamfetamine / Generic mfg.
Enrollment change, MRI: LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women (clinicaltrials.gov) - May 1, 2014
P4, N=14, Completed, Sponsor: University of Pennsylvania
Trial completion date: Jan 2014 --> Apr 2014 N=24 --> 14
- ||| lisdexamfetamine / Generic mfg.
Enrollment change: Attention & Memory Impairments in Menopausal Women (clinicaltrials.gov) - May 1, 2014
P4, N=57, Completed, Sponsor: University of Pennsylvania
N=24 --> 14 N=34 --> 57
- | lisdexamfetamine / Generic mfg.
Trial completion, MRI: LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women (clinicaltrials.gov) - May 1, 2014
P4, N=14, Completed, Sponsor: University of Pennsylvania
N=34 --> 57 Recruiting --> Completed
- |||| lisdexamfetamine / Generic mfg.
Trial completion: Attention & Memory Impairments in Menopausal Women (clinicaltrials.gov) - May 1, 2014
P4, N=57, Completed, Sponsor: University of Pennsylvania
Recruiting --> Completed Active, not recruiting --> Completed
- ||| lisdexamfetamine / Generic mfg.
Enrollment closed: Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder (clinicaltrials.gov) - Apr 7, 2014
P4, N=542, Active, not recruiting, Sponsor: Shire
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- lisdexamfetamine / Generic mfg.
Enrollment change: Effects of LDX on Functioning of College Students With ADHD (clinicaltrials.gov) - Apr 6, 2014
P4, N=50, Completed, Sponsor: University of Rhode Island
Recruiting --> Active, not recruiting N=24 --> 50
- lisdexamfetamine / Generic mfg.
Trial termination: Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression (clinicaltrials.gov) - Mar 27, 2014
P3, N=25, Terminated, Sponsor: Lindner Center of HOPE
N=24 --> 50 Recruiting --> Terminated; Enrollment goals not met
- lisdexamfetamine / Generic mfg.
Enrollment change: Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression (clinicaltrials.gov) - Mar 27, 2014
P3, N=25, Terminated, Sponsor: Lindner Center of HOPE
Recruiting --> Terminated; Enrollment goals not met N=50 --> 25
- | lisdexamfetamine / Generic mfg.
Trial termination, Combination therapy: SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study (clinicaltrials.gov) - Mar 4, 2014
P3, N=1571, Terminated, Sponsor: Shire
Enrolling by invitation --> Terminated; SPD489 failed to demonstrate a benefit as adjunctive treatment to antidepressants. Termination was not related to any new safety findings.
- lisdexamfetamine / Generic mfg.
Trial termination: Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression (clinicaltrials.gov) - Mar 3, 2014
P3, N=50, Terminated, Sponsor: Lindner Center of HOPE
Termination was not related to any new safety findings. Recruiting --> Terminated; Sponsor halted study.
- lisdexamfetamine / Generic mfg.
Trial completion, Combination therapy: SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder (clinicaltrials.gov) - Feb 10, 2014
P2, N=1197, Completed, Sponsor: Shire Development LLC
Recruiting --> Terminated; Sponsor halted study. Active, not recruiting --> Completed
- lisdexamfetamine / Generic mfg.
Trial completion: Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder (clinicaltrials.gov) - Feb 9, 2014
P4, N=464, Completed, Sponsor: Shire Development LLC
Active, not recruiting --> Completed Recruiting --> Completed
- |||||| lisdexamfetamine / Generic mfg.
Enrollment open: Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder (clinicaltrials.gov) - Jan 28, 2014
P3, N=412, Recruiting, Sponsor: Shire
Recruiting --> Completed Not yet recruiting --> Recruiting
- lisdexamfetamine / Generic mfg.
New P1 trial: Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence (clinicaltrials.gov) - Jan 9, 2014
P1, N=60, Not yet recruiting, Sponsor: University of Arkansas
- | lisdexamfetamine / Generic mfg.
Enrollment change, Combination therapy: Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder (clinicaltrials.gov) - Dec 18, 2013
P3, N=1262, Completed, Sponsor: Shire Development LLC
Not yet recruiting --> Recruiting N=1034 --> 1262
- | lisdexamfetamine / Generic mfg.
Trial completion, Combination therapy: Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder (clinicaltrials.gov) - Dec 18, 2013
P3, N=1262, Completed, Sponsor: Shire Development LLC
N=1034 --> 1262 Recruiting --> Completed
- | lisdexamfetamine / Generic mfg.
Enrollment closed: Open Label Extension in Adults With Binge Eating Disorder (BED) (clinicaltrials.gov) - Dec 12, 2013
P3, N=530, Active, not recruiting, Sponsor: Shire Development LLC
Recruiting --> Completed Recruiting --> Active, not recruiting
- | lisdexamfetamine / Generic mfg.
Trial completion, Combination therapy: Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder (clinicaltrials.gov) - Dec 12, 2013
P3, N=1105, Completed, Sponsor: Shire Development LLC
Recruiting --> Active, not recruiting Recruiting --> Completed
- |||||||||| lisdexamfetamine / Generic mfg.
New P3 trial: Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder (clinicaltrials.gov) - Dec 9, 2013
P3, N=412, Recruiting, Sponsor: Shire